ContractIndividual Clinical Trial Agreement (Icta) • February 8th, 2022
RECITALS WHEREAS, Sponsor and Provider of healthcare entered into a Master Clinical Trial Agreement (“Agreement”) effective on 16 October 2017, which regulates and integrates the provisions of the ICTA; andWHEREAS, pursuant to Section 2 of the Agreement, Sponsor and Provider of healthcare wish to enter into this ICTA for the purpose of setting forth the Protocol Number, Protocol Title and specific terms and conditions for the conduct of an individual clinical trial; andNOW, THEREFORE, pursuant to and subject to the terms and conditions of the Agreement and in consideration of the promises and mutual covenants contained herein, the Parties agree to the following: ÚVODNÍ USTANOVENÍ VZHLEDEM K TOMU, ŽE Zadavatel a Poskytovatel zdravotních služeb uzavřeli s účinností ke dni 16. 10. 2017 Rámcovou smlouvu o klinickém hodnocení (dále jen„Smlouva“), která upravuje a integruje tuto SKKH; aVZHLEDEM K TOMU, ŽE podleustanovení článku 2 Smlouvy si Zadavatel a Poskytovatel zdravotních služeb přejí u
